These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6216966)

  • 41. Urinary tract infection due to laboratory-acquired Escherichia coli: relation to virulence.
    Parry SH; Abraham SN; Feavers IM; Lee M; Jones MR; Bint AJ; Sussman M
    Br Med J (Clin Res Ed); 1981 Mar; 282(6268):949-50. PubMed ID: 6781667
    [No Abstract]   [Full Text] [Related]  

  • 42. Pathogenicity islands of uropathogenic E. coli and evolution of virulence.
    Blum-Oehler G; Dobrindt U; Janke B; Nagy G; Piechaczek K; Hacker J
    Adv Exp Med Biol; 2000; 485():25-32. PubMed ID: 11109083
    [No Abstract]   [Full Text] [Related]  

  • 43. [Biological and molecular characteristics of uropathogenic Escherichia coli strains isolated in the city of Rio de Janeiro].
    Esparis CM; Teixeira LM; Irino K; Gil PF; Almeida MM; Lopes GS; Bravo VL; Pacheco RS; Regua-Mangia AH
    Rev Soc Bras Med Trop; 2006; 39(6):573-6. PubMed ID: 17308707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic characterization of the uropathogenic E. coli strain 536--a subtractive hybridization analysis.
    Janke B; Hacker J; Blum-Oehler G
    Adv Exp Med Biol; 2000; 485():53-6. PubMed ID: 11109086
    [No Abstract]   [Full Text] [Related]  

  • 45. [Experimental urinary tract infection in mice to evaluate the pathogenicity of Escherichia coli isolated from newborn infants and their mothers].
    Kakuno Y; Honda M; Takakura K
    Kansenshogaku Zasshi; 1988 Dec; 62(12):1138-42. PubMed ID: 3148011
    [No Abstract]   [Full Text] [Related]  

  • 46. [A novel function for renal collecting duct intercalated cells: defense against uropathogenic Escherichia coli].
    Chassin C; Goujon JM; Le Bouguénec C; Buzoni-Gatel D; Vandewalle A
    Med Sci (Paris); 2007 Jan; 23(1):32-4. PubMed ID: 17212928
    [No Abstract]   [Full Text] [Related]  

  • 47. Structure of the capsular polysaccharide (K19 antigen) from uropathogenic Escherichia coli O25:K19:H12.
    Jann B; Ahrens R; Dengler T; Jann K
    Carbohydr Res; 1988 Jun; 177():273-7. PubMed ID: 3048659
    [No Abstract]   [Full Text] [Related]  

  • 48. Relation of virulence of Escherichia coli in septicemia and urinary tract infection to temperature-sensitive growth in minimal medium.
    Spurgeon L; Thrupp LD
    J Infect Dis; 1980 Nov; 142(5):773. PubMed ID: 7007521
    [No Abstract]   [Full Text] [Related]  

  • 49. Complex effects of pulsed infrared laser and asparaginase on Escherichia coli strains isolated from patients with urinary diseases.
    Kolganova TV; Dzharadat T; Ermolaev AV; Osipova IG; Vasil'eva EA; Dalin MV; Doyle RJ
    Bull Exp Biol Med; 2002 Jun; 133(6):591-3. PubMed ID: 12447475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Escherichia coli strains producing hydrogen sulfide in iron-agar medium.
    Braunstein H; Mladineo MA
    Am J Clin Pathol; 1974 Sep; 62(3):420-4. PubMed ID: 4606524
    [No Abstract]   [Full Text] [Related]  

  • 51. Properties of Escherichia coli isolated from urinary-tract infections, introital swabs and faeces.
    Cooke EM; Ewins SP
    J Med Microbiol; 1972 Nov; 5(4):Pxi. PubMed ID: 4566882
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of cyclosporin on uropathogenic Escherichia coli adherence to human endothelial cells.
    Szkaradkiewicz A; Wal M
    Int J Antimicrob Agents; 2001 Jul; 18(1):89-91. PubMed ID: 11463534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virulence factors predict Escherichia coli colonization patterns among human and animal household members.
    Murray AC; Kuskowski MA; Johnson JR
    Ann Intern Med; 2004 May; 140(10):848-9. PubMed ID: 15148084
    [No Abstract]   [Full Text] [Related]  

  • 54. [Escherichia coli antibodies in urinary tract infections].
    Akan E; Aksungur P; Kobal C; Zeybekoğlu M
    Turk Hij Tecr Biyol Derg (1961); 1976; 36(2):248-55. PubMed ID: 799384
    [No Abstract]   [Full Text] [Related]  

  • 55. [On the experimental pathogenic power of certain strains of the Escherichia species].
    Filotti A
    Arch Roum Pathol Exp Microbiol; 1965 Dec; 24(4):843-50. PubMed ID: 5339167
    [No Abstract]   [Full Text] [Related]  

  • 56. A carbohydrate biosensor surface for the detection of uropathogenic bacteria.
    Nilsson KG; Mandenius CF
    Biotechnology (N Y); 1994 Dec; 12(13):1376-8. PubMed ID: 7765569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in the molecular basis of pathogen recognition and host responses in the urinary tract.
    Schilling JD; Hultgren SJ; Lorenz RG
    Int Rev Immunol; 2002; 21(4-5):291-304. PubMed ID: 12486816
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification of a complete dfrA14 gene cassette integrated at a secondary site in a resistance plasmid of uropathogenic Escherichia coli from Nigeria.
    Ojo KK; Kehrenberg C; Schwarz S; Odelola HA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2054-5. PubMed ID: 12019141
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bacteriologic and immunologic study of E. coli urinary tract infection].
    Kato T
    Nihon Hinyokika Gakkai Zasshi; 1968 Dec; 59(12):1061-83. PubMed ID: 4887312
    [No Abstract]   [Full Text] [Related]  

  • 60. [Octogenarian with infectious endocarditis over native valve due to E. coli].
    Magallanes Gamboa JO; Notario Barba V; Marcos Sánchez F
    Rev Esp Geriatr Gerontol; 2020; 55(1):58-59. PubMed ID: 31303344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.